Literature DB >> 21338097

Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery.

Qinghuan Zhao1, Weihong Chen, Yuanding Chen, Liming Zhang, Jinping Zhang, Zhijun Zhang.   

Abstract

Proteins of viral capsid may self-assemble into virus-like particles (VLPs) that can find many biomedical applications such as platform for drug delivery. In this paper, we describe preparation of VLPs by self-assembly of VP6, a rotavirus capsid protein that was chemically conjugated with doxorubicin (DOX), an anticancer drug. VP6 was first highly expressed in E. Coli, followed by purification and renaturation. DOX was then covalently attached to VP6 to form DOX-VP6 (DVP6) conjugates, which were subsequently self-assembled into VLPs under appropriate condition. Next, lactobionic acid (LA) was chemically linked to the surface of the VLPs. We demonstrated that the aforementioned nanosystem shows specific targeting to hepatoma cell line HepG2. The chemically functionalized VLPs, a kind of biological nanoparticles with excellent biocompatibility and biodegradability, can be prepared in large scale from E. Coli through our method, which may find practical applications in biomedicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338097     DOI: 10.1021/bc1002532

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  29 in total

1.  Engineering of Brome mosaic virus for biomedical applications.

Authors:  Ibrahim Yildiz; Irina Tsvetkova; Amy M Wen; Sourabh Shukla; M Hema Masarapu; Bogdan Dragnea; Nicole F Steinmetz
Journal:  RSC Adv       Date:  2012-01-23       Impact factor: 3.361

Review 2.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

3.  CPMV-DOX delivers.

Authors:  Alaa A A Aljabali; Sourabh Shukla; George P Lomonossoff; Nicole F Steinmetz; David J Evans
Journal:  Mol Pharm       Date:  2012-08-06       Impact factor: 4.939

4.  A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins.

Authors:  Yumei Teng; Bingxin Zhao; Xiaoxia Pan; Yuling Wen; Yuanding Chen
Journal:  Viral Immunol       Date:  2014-04-04       Impact factor: 2.257

5.  Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.

Authors:  Hema Masarapu; Bindi K Patel; Paul L Chariou; He Hu; Neetu M Gulati; Bradley L Carpenter; Reza A Ghiladi; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomacromolecules       Date:  2017-11-16       Impact factor: 6.988

6.  Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.

Authors:  Dawei Ding; Xiaolei Tang; Xiaoli Cao; Jinhui Wu; Ahu Yuan; Qian Qiao; Jing Pan; Yiqiao Hu
Journal:  AAPS PharmSciTech       Date:  2013-11-28       Impact factor: 3.246

7.  Photodynamic activity of viral nanoparticles conjugated with C60.

Authors:  Amy M Wen; Mary J Ryan; Alice C Yang; Kurt Breitenkamp; Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Chem Commun (Camb)       Date:  2012-08-02       Impact factor: 6.222

Review 8.  Caged protein nanoparticles for drug delivery.

Authors:  Nicholas M Molino; Szu-Wen Wang
Journal:  Curr Opin Biotechnol       Date:  2014-01-08       Impact factor: 9.740

9.  Quantum Dots Encapsulated with Canine Parvovirus-Like Particles Improving the Cellular Targeted Labeling.

Authors:  Dan Yan; Bin Wang; Shiqi Sun; Xia Feng; Ye Jin; Xueping Yao; Suizhong Cao; Huichen Guo
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

Review 10.  Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.

Authors:  Daniela Wojta-Stremayr; Winfried F Pickl
Journal:  Sensors (Basel)       Date:  2013-07-08       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.